Locations:

Tag: Epidermal growth factor receptor (EGFR)

23-CNR-4044611-CQD-Hero-650×450. Dr Chaojpg

October 16, 2023/Cancer/Research

Adding EGFR-Directed Systemic Treatment of Stereotactic Radiosurgery May Improve Control of Brain Metastases in Non-Small Cell Lung Cancer

New review published in Cancers suggests a synergistic benefit

23-CNR-3898262-CQD-Hero-650×450 Yilmaz ASCO 2023

June 7, 2023/Cancer/Research

First-in-Class Bifunctional EGFR Inhibitor Shows Promising Activity in Metastatic Head and Neck Cancers, Especially When Given with Immunotherapy

Combination therapy demonstrates effectiveness in first-line treatment setting

June 29, 2021/Cancer/Tumor Oncology

Achieving Cost-Effectiveness with Adjuvant Osimertinib for NSCLC

Model identifies target OS at which economic benefits of treatment outpace placebo

20-PSX-1944054-Cutaneous-adverseEffects-TFGRs-2-CQD_650x450

August 13, 2020/Cancer

Cutaneous Adverse Effects of Epidermal Growth Factor Receptor Inhibitors

When to consult a dermatologist

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next